The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Digital Edition Archives Authors Reviewers

Page 16

More JCP Articles

JCP
Lower Risk of Cardiovascular Disorders in Antidepressant-Treated Women Veterans: Encouraging Findings but Concerns Remain
Commentary

May 7, 2025

Comments on a study by Sumner et al that followed 609,546 women veterans for a mean of 8.8 years to look at associations of antidepressants with incident CVD.
JCP
Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment
Consensus Statement

May 7, 2025

Consensus recommendations about the goals of a consultation for treatment-resistant depression include establishing the primary diagnosis and comorbidities, clarifying symptoms, identifying goals, documenting treatment history, identifying treatment barriers, and…
, , , et al
JCP
Antidepressants and Incident Cardiovascular Disease in Women Veterans
Original Research

May 7, 2025

SSRIs, SNRIs, and other antidepressants were each associated with lower incidence of cardiovascular disease and stroke in this sample of women Veterans.
, , , et al
JCP
Vortioxetine for Cognitive Impairment in MDD Post-COVID
Original Research

May 5, 2025

Measures of cognitive function and depressive symptoms improved to a greater extent with vortioxetine than with escitalopram or sertraline in post-COVID syndrome participants with MDD.
, , , et al
JCP
Increased Risk of Suicide Attempt in Patients With Atopic Dermatitis
Original Research

May 5, 2025

People with atopic dermatitis had an elevated risk of suicide attempts, with an adjusted hazard ratio of 3.44.
, , , et al
JCP
Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians
ASCP Corner

May 5, 2025

While the abolition of REMS for clozapine expands access, the change could create confusion. Among the most relevant examples are mismatches between FDA recommendations for lifetime monitoring and the…
,
JCP
Correction

May 2, 2025

JCP
Erecting Barriers to Suicide by Removing Barriers to Science
Letter to the Editor

April 30, 2025

The authors comment on the implications of a recent NSF communication warning researchers about the use of certain terms in grant proposals and publications made possible with government funding.
, , , et al
JCP
Adjunctive Cariprazine for Anxiety Symptoms in MDD
Original Research

April 30, 2025

Cariprazine added to antidepressant therapy reduced anxiety symptoms in patients with and without anxiety at baseline.
, , , et al
JCP
Public Health Nurse–Delivered 1-Day CBT for Postpartum Depression
Original Research

April 30, 2025

Pilot results suggest that 1-day CBT-based workshops may lead to improvements in postpartum depression up to 9 months later.
, , , et al
JCP
Defense Mechanisms and Common Psychiatric Disorders
Original Research

April 28, 2025

Individuals with mood, anxiety, or substance use disorders generally had a higher prevalence of defense mechanisms than those with no disorders. Defense mechanisms and psychiatric disorders represent correlated but…
, , , et al
JCP
Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations
Consensus Statement

April 28, 2025

Key practical considerations are described, including systems-level and financial issues; equity and access to TRD care for a diverse population; selecting a target population and facilitating referrals; communication between…
, , , et al

Insightful. Evidence-based. Human-centered.

Listen to the JCP Podcast Now
Figure: Digital illustration shows a human head with neural connections and podcast title over a dark blue patterned background.

Subscribe to read
more articles

Subscribe